Several case reports and reviews have identified G-CSF—particularly pegfilgrastim—as a potential trigger for LVV, manifesting as aortitis or arteritis, often accompanied by systemic symptoms such as fever, malaise, and elevated inflammatory markers. The gene discussed is CSF3; the disease is arteritis.